Tag: stage

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a genetic disorder caused by a chromosome 22 deletion, presenting symptoms like heart defects, immune deficiencies, and developmental delays. Market growth is driven by advancements in diagnostic technologies like next-generation sequencing (NGS) and chromosomal microarray analysis (CMA), enabling early detection and tailored interventions. Despite the lack of a cure, targeted therapies, such as Zynerba Pharmaceuticals' Zygel, are emerging. Increased awareness, research funding, and strategic collaborations are enhancing patient care and shaping a promising future for the 22q11.2 deletion syndrome market.

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a genetic disorder caused by a chromosome 22 deletion, presenting symptoms like heart defects, immune deficiencies, and developmental delays. Market growth is driven by advancements in diagnostic technologies like next-generation sequencing (NGS) and chromosomal microarray analysis (CMA), enabling early detection and tailored interventions. Despite the lack of a cure, targeted therapies, such as Zynerba Pharmaceuticals' Zygel, are emerging. Increased awareness, research funding, and strategic collaborations are enhancing patient care and shaping a promising future for the 22q11.2 deletion syndrome market.

Dr. Anosh Ahmed expands U.S. and international COVID testing contracts with focus on compliance, fraud prevention, and trusted public health services

Dr. Anosh Ahmed expands U.S. and international COVID testing contracts with focus on compliance, fraud prevention, and trusted public health services

ASHP Survey Reports Growth in Pharmacy Roles in Hospital and Ambulatory Care BETHESDA, Md., June 25, 2025 /PRNewswire/ -- Health-system pharmacists are playing a larger role...

Ethical AI meets music creation as Wondera trains with rights-cleared songs, building trust with artists and the future of generative music. NEW YORK, June 25,...

Ignis Energy, a geothermal exploration and development company, today announced the final close of its Series A funding round, securing $13.6 million.

NEW YORK, June 25, 2025 /PRNewswire/ -- This is where money does business. The New York Stock Exchange (NYSE) recently traveled to Amsterdam in collaboration...

Starting today, applications are open for the Maesa Magic Incubator Class of 2026. NEW YORK, June 25, 2025 /PRNewswire/ -- Maesa, the Next-Gen Beauty Company,...

Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test

Hole MD-047 intercepted visible copper and molybdenum mineralization from surface to the end of the hole (EOH). First 489m assayed 0.45% CuEq* (0.35% Cu...

Zapp EV Reports Financial Results for the Six Months Ended March 31, 2025 and Provides Operational Update

HANGZHOU, China, June 25, 2025 /PRNewswire/ -- On June 14, 2025, the 3rd Global Sportswear Design Award officially launched at the China National Silk...

GEORGE TOWN, Cayman Islands, June 25, 2025 (GLOBE NEWSWIRE) -- Toobit, the award-winning global cryptocurrency exchange, today introduces DEX+, a powerful new feature that simplifies on-chain trading. This allows users to access and trade a wide array of early-stage, trending, and high-potential on-chain assets directly from their Toobit Spot account.

BALI, Indonesia, June 25, 2025 /PRNewswire/ -- Tucked in the vibrant village of Pererenan, Shelter Bali has quickly become a must-visit dining destination for food...

MELBOURNE, Australia and INDIANAPOLIS, June 25, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that its Telix Manufacturing...